ASX Research

[BUY] Collins Foods (ASX: CKF) – Qld and WA Exposure Outweighs the Wage Cost Squeeze

Jun 10, 2026 | Research

Collins Foods (ASX: CKF) at A$8.27 trades ~20% below its historical PE. Qld/WA exposure plus a kiosk rollout offset wage pressure. 29% upside, Buy.

[BUY] Worley (ASX: WOR) – Bigger Addressable Market, Same Margin Profile

Jun 1, 2026 | Research

Worley (ASX: WOR) at A$12.19 trades at a 21% discount to its 5yr average and 14% below global peers. New power and data centre markets expand the TAM. Buy.

[BUY] WEB Travel Group (ASX: WEB): Near-Term Headwinds Create a Value Entry Point

May 25, 2026 | Research

Institutional sell-side rates WEB Travel Group a Buy with a 12-month price target of A$4.70. The stock closed at A$2.23 on 20 May 2026, implying...

[BUY] Aristocrat Leisure (ASX: ALL): Gaming Share Gains, a Billion-Dollar Buyback and a Compressing Multiple

May 18, 2026 | Research

Aristocrat Leisure carries a Buy rating with 33 per cent upside to a A$61 target. Gaming net adds are tracking above guidance, the buyback has been lifted to A$1 billion, and the P/E compresses from 27x to 14x by FY28.

[BUY] Nick Scali (ASX: NCK): Margins, Growth and a Franked Yield

May 11, 2026 | Research

Institutional sell-side rates Nick Scali a Buy with a 12-month price target of around A$20. The stock closed at approximately A$14.47 on 9 May 2026,...

[BUY] ResMed (ASX: RMD) – A New Product Cycle and a Cheap Multiple

May 4, 2026 | Research

ResMed reported its 3Q26 result this week. We are reiterating our Buy view on the stock with a price target of A$46.20, against a closing price of...

[SELL] Macquarie Group (ASX: MQG) Why a 21% Rally Into Earnings Looks Stretched

Apr 27, 2026 | Research

Macquarie has rallied more than 21% in the past month, pushing the multiple to 24x forward earnings against a 10-year average of 16x. We walk through why the valuation looks stretched, the bull-case rebuttals (Aligned Data Centers, Qube), and why FY26 result on 8 May is the decision point.